Literature DB >> 26788232

Local tumour ablation for localized kidney cancer: Practice patterns in Canada.

Vincent Trudeau1, Alessandro Larcher2, Paolo Dell'Oglio2, Katharina Boehm3, Mohamed Bishr1, Pierre I Karakiewicz1.   

Abstract

INTRODUCTION: Local tumour ablation (LTA) is a recommended option for the treatment of localized kidney cancer in nonsurgical candidates. We performed a survey to describe the practice patterns of this procedure in Canada.
METHODS: An electronic survey was sent by email to all urologists registered to the Canadian Urological Association (CUA). Urologists were queried about general demographic information, LTA availability at their institution (and reasons for non-availability, if it was the case), as well as the type and context of LTA use.
RESULTS: Overall, 103 individual responses were obtained (response rate of 19.5%). Of those, 58 (56.3%) had access to LTA at their institution. Urologists who had access to LTA were more likely to work at an academic institution (69 vs. 16%, p<0.001). Among individuals who did not use LTA, the main reasons were lack of staff, such as radiologists, who can assist and/or perform the procedure (64%); and lack of expertise with the procedure (62%). Among urologists who had access to LTA, percutaneous radiofrequency and cryoablation were the most commonly used (72% and 21%, respectively); however, urologists were rarely involved in those procedures (12%).
CONCLUSIONS: In this national survey, we found that a significant proportion of Canadian urologists did not have access to LTA. We also found that when LTA was performed, urologists were rarely involved in the procedures. Those findings represent significant areas for improvement in the access to LTA. The conclusions of this study are limited by the low response rate.

Entities:  

Year:  2015        PMID: 26788232      PMCID: PMC4707895          DOI: 10.5489/cuaj.3317

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  6 in total

1.  Surgeon-specific factors affecting treatment decisions among Canadian urologists in the management of pT1a renal tumours.

Authors:  Alexandra Leora Millman; Kenneth T Pace; Michael Ordon; Jason Young Lee
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

2.  Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.

Authors:  Gideon Lorber; Michael Glamore; Mehul Doshi; Merce Jorda; Gaston Morillo-Burgos; Raymond J Leveillee
Journal:  Urol Oncol       Date:  2014-07-02       Impact factor: 3.498

3.  Ablation of small renal masses: practice patterns at academic institutions in the United States.

Authors:  Sutchin R Patel; E Jason Abel; Sean P Hedican; Stephen Y Nakada
Journal:  J Endourol       Date:  2012-11-19       Impact factor: 2.942

Review 4.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

5.  Current practice patterns in the use of ablation technology for the management of small renal masses at academic centers in the United States.

Authors:  Gaurav Bandi; Sean P Hedican; Stephen Y Nakada
Journal:  Urology       Date:  2008-01       Impact factor: 2.649

6.  Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses.

Authors:  Alessandro Larcher; Nicola Fossati; Francesco Mistretta; Giovanni Lughezzani; Giuliana Lista; Paolo Dell'Oglio; Alberto Abrate; Maxine Sun; Pierre Karakiewicz; Nazareno Suardi; Massimo Lazzeri; Francesco Montorsi; Giorgio Guazzoni; Nicolò Buffi
Journal:  Urol Oncol       Date:  2014-10-07       Impact factor: 3.498

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.